State Street Corp Emergent Bio Solutions Inc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, State Street Corp holds 1,963,764 shares of EBS stock, worth $16.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,963,764

Previous 1,911,327 2.74%

Holding current value

$16.4 Million

Previous $16 Million 17.63%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$7.72 - $11.97 $404,813 - $627,670	52,437 Added 2.74%	1,963,764 $18.8 Million
Q3 2024 Nov 14, 2024	BUY	$5.72 - $14.77 $9.8 Million - $25.3 Million	1,713,200 Added 864.7%	1,911,327 $16 Million
Q2 2024 Aug 14, 2024	SELL	$1.86 - $6.98 $1.6 Million - $6 Million	-859,466 Reduced 81.27%	198,127 $1.35 Million
Q1 2024 May 15, 2024	SELL	$1.5 - $3.41 $8,037 - $18,270	-5,358 Reduced 0.5%	1,057,593 $2.68 Million
Q4 2023 Feb 14, 2024	SELL	$1.82 - $3.16 $125,587 - $218,052	-69,004 Reduced 6.1%	1,062,951 $2.55 Million
Q3 2023 Nov 14, 2023	SELL	$3.17 - $7.91 $17.9 Million - $44.8 Million	-5,662,189 Reduced 83.34%	1,131,955 $3.85 Million
Q2 2023 Aug 14, 2023	BUY	$7.35 - $13.21 $10.2 Million - $18.3 Million	1,388,594 Added 25.69%	6,794,144 $49.9 Million
Q1 2023 May 15, 2023	SELL	$7.79 - $16.29 $3.21 Million - $6.72 Million	-412,405 Reduced 7.09%	5,405,550 $56 Million
Q4 2022 Feb 14, 2023	BUY	$11.0 - $21.45 $16.5 Million - $32.2 Million	1,501,645 Added 34.79%	5,817,955 $68.7 Million
Q3 2022 Nov 15, 2022	BUY	$20.09 - $35.8 $3.33 Million - $5.93 Million	165,678 Added 3.99%	4,316,310 $90.6 Million
Q2 2022 Aug 15, 2022	BUY	$27.42 - $43.63 $18.7 Million - $29.7 Million	681,162 Added 19.63%	4,150,632 $129 Million
Q1 2022 May 16, 2022	BUY	$36.48 - $52.22 $15.9 Million - $22.8 Million	436,743 Added 14.4%	3,469,470 $142 Million
Q4 2021 Feb 14, 2022	BUY	$33.11 - $55.01 $20.8 Million - $34.6 Million	628,137 Added 26.12%	3,032,727 $132 Million
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $13.7 Million - $18 Million	273,127 Added 12.81%	2,404,590 $120 Million
Q2 2021 Aug 16, 2021	BUY	$56.61 - $80.46 $12.3 Million - $17.5 Million	217,984 Added 11.39%	2,131,463 $134 Million
Q1 2021 May 17, 2021	SELL	$86.23 - $125.19 $20 Million - $29.1 Million	-232,112 Reduced 10.82%	1,913,479 $178 Million
Q4 2020 Feb 16, 2021	BUY	$79.17 - $111.47 $22.4 Million - $31.6 Million	283,423 Added 15.22%	2,145,591 $192 Million
Q3 2020 Nov 10, 2020	SELL	$81.91 - $134.94 $29.5 Million - $48.7 Million	-360,542 Reduced 16.22%	1,862,168 $192 Million
Q2 2020 Aug 14, 2020	BUY	$54.33 - $89.52 $2.6 Million - $4.29 Million	47,929 Added 2.2%	2,222,710 $176 Million
Q1 2020 May 11, 2020	BUY	$49.34 - $68.76 $107 Million - $150 Million	2,174,781 New	2,174,781 $126 Million

Others Institutions Holding EBS

# of Institutions

172

Shares Held

36.8M

Call Options Held

336K

Put Options Held

203K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $416M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Emergent Bio Solutions Inc. Transaction History